Clinical Trial Update: Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating nab-paclitaxel in combination with paclitaxel and ramucirumab for clinical stage IVB gastric cancer with peritoneal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Peritoneal Metastasis

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Cyramza (ramucirumab)
• Taxol (paclitaxel)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Clinical Stage IVB Gastric Cancer AJCC v8, Metastatic Gastric Adenocarcinoma | Phase 1 | Status: RECRUITING